An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the long term safety and efficacy of telmisartan plus amlodipine FDC in patients
with essential hypertension who failed to control their BP with either monotherapy